DE69202075D1 - Polyhydroxycyclopentan Derivate, ihre Herstellung und ihre therapeutische Verwendung. - Google Patents

Polyhydroxycyclopentan Derivate, ihre Herstellung und ihre therapeutische Verwendung.

Info

Publication number
DE69202075D1
DE69202075D1 DE69202075T DE69202075T DE69202075D1 DE 69202075 D1 DE69202075 D1 DE 69202075D1 DE 69202075 T DE69202075 T DE 69202075T DE 69202075 T DE69202075 T DE 69202075T DE 69202075 D1 DE69202075 D1 DE 69202075D1
Authority
DE
Germany
Prior art keywords
hydroxymethyl
amino
polyhydroxycyclopentane
derivatives
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69202075T
Other languages
English (en)
Other versions
DE69202075T2 (de
Inventor
Nakajima C O Sankyo Com Mutsuo
Ando C O Sankyo Company Osamu
Takahashi C O Sankyo Com Shuji
Hamano C O Sankyo Comp Kiyoshi
Haruyama C O Sankyo C Hideyuki
Kinoshita C O Sankyo C Takeshi
Sato C O Sankyo Company Akira
Takamatsu C O Sankyo Yasuyuki
Enokita C O Sankyo Compa Ryuzo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Application granted granted Critical
Publication of DE69202075D1 publication Critical patent/DE69202075D1/de
Publication of DE69202075T2 publication Critical patent/DE69202075T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/44—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton bound to carbon atoms of the same ring or condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/14—Nitrogen or oxygen as hetero atom and at least one other diverse hetero ring atom in the same ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Volume Flow (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Lubricants (AREA)
  • Materials For Photolithography (AREA)
DE69202075T 1991-02-15 1992-02-17 Polyhydroxycyclopentan Derivate, ihre Herstellung und ihre therapeutische Verwendung. Expired - Fee Related DE69202075T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2197691 1991-02-15
JP13294691 1991-06-04
JP21345091 1991-08-26
JP27241291 1991-10-21

Publications (2)

Publication Number Publication Date
DE69202075D1 true DE69202075D1 (de) 1995-05-24
DE69202075T2 DE69202075T2 (de) 1996-01-11

Family

ID=27457670

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69202075T Expired - Fee Related DE69202075T2 (de) 1991-02-15 1992-02-17 Polyhydroxycyclopentan Derivate, ihre Herstellung und ihre therapeutische Verwendung.

Country Status (20)

Country Link
US (1) US5260447A (de)
EP (1) EP0499489B1 (de)
KR (4) KR100226305B1 (de)
CN (1) CN1043422C (de)
AT (1) ATE121383T1 (de)
AU (1) AU653384B2 (de)
CA (1) CA2061239C (de)
CZ (2) CZ281476B6 (de)
DE (1) DE69202075T2 (de)
DK (1) DK0499489T3 (de)
ES (1) ES2074332T3 (de)
FI (1) FI920663A (de)
HK (1) HK117796A (de)
HU (1) HU214702B (de)
IE (1) IE71947B1 (de)
IL (1) IL100955A (de)
IS (4) IS3815A (de)
NO (1) NO177589C (de)
NZ (1) NZ241623A (de)
TW (1) TW221804B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1131672A (zh) * 1994-11-22 1996-09-25 生化学工业株式会社 氨基环戊烷衍生物
AU4335997A (en) * 1996-09-09 1998-03-26 Wisconsin Alumni Research Foundation Human salivary proteins and fragments thereof having alpha-glucosidase inhibitory activity
US6770468B1 (en) 1999-09-14 2004-08-03 Genzyme Glycobiology Research Institute, Inc. Phosphodiester-α-GlcNAcase of the lysosomal targeting pathway
US6537785B1 (en) 1999-09-14 2003-03-25 Genzyme Glycobiology Research Institute, Inc. Methods of treating lysosomal storage diseases
US6800472B2 (en) 2001-12-21 2004-10-05 Genzyme Glycobiology Research Institute, Inc. Expression of lysosomal hydrolase in cells expressing pro-N-acetylglucosamine-1-phosphodiester α-N-acetyl glucosimanidase
US6905856B2 (en) 2001-12-21 2005-06-14 Genzyme Glycobiology Research Institute, Inc. Soluble GlcNAc phosphotransferase
KR101583080B1 (ko) * 2009-03-12 2016-01-07 엘지전자 주식회사 공기조화장치용 실외기
CN104758275A (zh) * 2015-03-05 2015-07-08 青岛申达高新技术开发有限公司 一种治疗结肠癌的药物组合物及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4138562A (en) * 1977-02-09 1979-02-06 The Regents Of The University Of Minnesota Adenosine deaminase resistant antiviral purine nucleosides and method of preparation
US4318562A (en) * 1980-03-03 1982-03-09 Libbey-Owens-Ford Company Grasping apparatus for handling heated articles
CH667649A5 (en) * 1986-09-10 1988-10-31 Lonza Ag 2-Substd. amino-benzoxazole and -benzimidazole derivs. prodn. - by reacting prim. amino cpd. with amine in presence of acid catalyst, useful as intermediates e.g. for pharmaceuticals
JP2529365B2 (ja) * 1988-10-17 1996-08-28 ダイハツ工業株式会社 ワ―クの積込積出装置
ATE105562T1 (de) * 1989-02-28 1994-05-15 Suntory Ltd Trehalostatin und seine herstellung.

Also Published As

Publication number Publication date
IS4066A (is) 1992-08-16
CN1043422C (zh) 1999-05-19
ES2074332T3 (es) 1995-09-01
NZ241623A (en) 1993-06-25
IE71947B1 (en) 1997-03-12
FI920663A0 (fi) 1992-02-14
EP0499489B1 (de) 1995-04-19
HU214702B (hu) 2000-03-28
FI920663A (fi) 1992-08-16
CS43992A3 (en) 1992-09-16
NO177589B (no) 1995-07-10
IS3815A (is) 1992-08-16
NO920555L (no) 1992-08-17
TW221804B (de) 1994-03-21
CA2061239A1 (en) 1992-08-16
ATE121383T1 (de) 1995-05-15
US5260447A (en) 1993-11-09
IS4064A (is) 1992-08-16
IL100955A0 (en) 1992-11-15
NO920555D0 (no) 1992-02-13
CZ281418B6 (cs) 1996-09-11
DE69202075T2 (de) 1996-01-11
NO177589C (no) 1995-10-18
HK117796A (en) 1996-07-12
HUT63845A (en) 1993-10-28
AU653384B2 (en) 1994-09-29
CA2061239C (en) 2002-04-09
KR100230626B1 (ko) 2000-03-15
AU1094792A (en) 1992-08-20
EP0499489A1 (de) 1992-08-19
KR100226305B1 (ko) 1999-10-15
HU9200455D0 (en) 1992-04-28
CN1064861A (zh) 1992-09-30
CZ51795A3 (en) 1996-09-11
IL100955A (en) 1997-03-18
KR920016401A (ko) 1992-09-24
IS4065A (is) 1992-08-16
IE920481A1 (en) 1992-08-26
KR100245477B1 (ko) 2000-03-15
DK0499489T3 (da) 1995-08-21
KR100229257B1 (ko) 2000-03-15
CZ281476B6 (cs) 1996-10-16

Similar Documents

Publication Publication Date Title
ES8705886A1 (es) Un metodo para preparar un derivadode tiazolidin-diona
ATE251141T1 (de) Benzamidin-derivate, deren herstellung und deren verwendung als anti-koagulantien
HU9200278D0 (en) 2,3,6.-substituted kinazolinon derivatives with angiotenzyn ii receptor blocing effect
ATE212345T1 (de) Heterocyclische verbindungen und ihre herstellung und verwendung
NO890259D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider.
CA2321188A1 (en) Derivatives of azetidine and pyrrolidine
ATE121383T1 (de) Polyhydroxycyclopentan derivate, ihre herstellung und ihre therapeutische verwendung.
HUP0001741A2 (hu) Antibakteriális hatású aza-biciklo-karbamoil-oxi-mutilin-származékok, eljárás ezek előállítására, ezeket tartalmazó készítmények és alkalmazásuk
MY113427A (en) Anti-neurodegeneratively active 10-aminoaliphatyl- dibenz [b,f] oxepines
DE69227583D1 (de) Arylmorpholine, herstellung und verwendung
NO991734L (no) Pyrazolinoner for behandling av potensforstyrrelser
ATE43140T1 (de) Derivate von enzym-hemmender griseolsaeure und deren verwendung.
DK56687A (da) 5-substitueret octahydroindolizinforbindelser samt 7-ketomellemprodukter ved fremstillingen heraf
DE60034110D1 (de) Verwendung von 4-aminopyridin zur behandlung von peripheren neuropathien
ES8604843A1 (es) Un metodo para la preparacion de un derivado de acetileno
FI980391A (fi) Polyhydroksisyklopentaanin johdannaiset, niiden valmistus ja terapeuttinen käyttö
DE69029069D1 (de) Verwendung von Xanthinderivaten gegen Magengeschwüre
NO974958D0 (no) Ny fremgangsmåte for fremstilling av (-)-trans-N-p-fluorbenzoylmetyl-4-(p-fluorfenyl)-3-[[3,4-(metylendioksy)-fenoksy]metyl]-piperidin
NO953573L (no) Benzopyraner som kaliumkanalåpnere
WO2001035938A3 (de) Pharmakologisch aktive tetrahydrothiopyran-4-ol-derivate, verfahren zu ihrer herstellung und verwendung
ES8605584A1 (es) Un procedimiento para preparar foroximitina
TH13336EX (th) อนุพันธ์พอลิไฮดรอกซิไซโคลเพนเทนการเตรียมและการใช้ประโยชน์เพื่อการรักษา
MX8232A (es) Derivados de triazolopirimidina.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee